Surgical implant devices and methods for their manufacture and use

Patent metadata

Field	Value
Publication number	US-9925033-B2
Application number	US-201615213125-A
Country	US
Kind code	B2
Filing date	Jul 18, 2016
Priority date	Jul 2, 2009
Publication date	Mar 27, 2018
Grant date	Mar 27, 2018

Abstract

This disclosure is directed toward sealable and repositionable implant devices that are provided with one or more improvements that increase the ability of implants such as endovascular grafts to be precisely deployed or re-deployed, with better in situ accommodation to the local anatomy of the targeted recipient anatomic site, and/or with the ability for post-deployment adjustment to accommodate anatomic changes that might compromise the efficacy of the implant.

First claim

We claim:

1. An endograft implant system, comprising:
an implant delivery catheter sized to be placed within an anatomic space comprising an internal wall, the implant delivery catheter comprising:
a sheath defining a lumen;
an external end; and
an internal end; and
an endograft implant at least one of compressed and folded within the lumen at the internal end of the implant delivery catheter lumen, the endograft implant comprising:
a tubular implant body comprising an elastic end and an implant lumen, the elastic end comprising a sealable circumferential collar having a diameter;
a variable sealing device contained within the sealable circumferential collar, the variable sealing device being operable to reversibly vary the diameter of the sealable circumferential collar;
a control lead releasably, directly, and mechanically connected to the variable sealing device to reversibly vary the diameter of the variable sealing device when the control lead is rotated; and
a plurality of retractable retention tines pivotally mounted within the variable sealing device such that, when the control lead is rotated to expand the diameter of the sealable circumferential collar, the retractable retention tines are exposed outwardly from the variable sealing device to engage the internal wall adjacent the elastic end and, when the control lead is rotated to reduce the diameter of the sealable circumferential collar, the retractable retention tines withdraw inwardly into the variable sealing device.

2. The endograft implant system according to claim 1 , wherein the implant delivery catheter and the sheath each have a length that allows advancement of the implant delivery catheter and the sheath into at least one of the thoracic aorta and the abdominal aorta.

3. The endograft implant system according to claim 1 , wherein the control lead traverses the implant delivery catheter and exits at the external end of the implant delivery catheter.

4. The endograft implant system according to claim 1 , wherein the variable sealing device comprises:
a sealer belt provided in an overlapping loop comprising a sealer belt channel, sealer gear retainment slots within the sealer belt channel, and two sealer belt channel side walls, the plurality of retention tines being pivotally mounted within the sealer belt channel, the retention tines within the outermost sealer belt channel circumference being disposed outwardly to engage an anatomic lumenal wall;
a compressible foam gasket contained within the sealer belt channel and situated between the sealer belt and an outermost circumference of the sealable circumferential collar;
a sealing device housing comprising a sealer gear having an axis parallel with the axis of the sealer belt and being rotatably mounted within the sealing device housing to interface with the sealer gear retainment slots; and
a spring interface within the sealer gear releasably connected to the control lead such that axial compression of the spring interface with the control lead unlocks a locking member and allows rotation of the sealer gear to reversibly vary the diameter of the variable sealing device.

5. The endograft implant system according to claim 4 , wherein the sealer belt is of at least one of titanium, stainless steel, a cobalt chromium alloy, a metal, a metal alloy, a polymer, a plastic, and a ceramic.

6. The endograft implant system according to claim 1 , wherein the sealable circumferential collar comprises an expandable mesh.

7. The endograft implant system according to claim 1 , wherein the sealable circumferential collar comprises one of:
a self-expandable mesh endoskeleton; and
a self-expandable mesh exoskeleton capable of self-expanding such that longitudinal traction on the expanded mesh reduces the circumference of the sealable circumferential collar.

8. The endograft implant system according to claim 1 , wherein the endograft implant comprises a biocompatible material or is coated with a biocompatible material.

9. The endograft implant system according to claim 8 , wherein the biocompatible material is a polymer comprising fluorinated monomer units selected from at least one of —CF2CF2-, —CH2CF2-, —CH2CHF—, —CHFCHF—, —CClFCF2-, —CF2C(CF3)F—, —CHFC(CF3)F—, —CF2C(CF3)H—, —CF2CRF—, —CHFCRF—, —CF2CRH—, —CH2CRF—, and —CFHCRH—, wherein R in each occurrence is selected independently from H, Cl, Br, I, methyl, ethyl, n-propyl, isopropyl, short chain alkyl groups, phenyl, substituted phenyl, cyclic alkyl, heterocyclic, heteroaryl, fluorinated short chain alkyl groups, fluorinated phenyl, fluorinated cyclic alkyl, fluorinated heterocyclic, or combinations thereof.

10. The endograft implant system according to claim 8 , wherein the endograft implant comprises a biocompatible material or is coated with a biocompatible material selected from at least one of poly(ethylene glycol) (PEG), polypropylene, poly(propylene glycol) (PPG), poly(N-vinyl pyrrolidone) (PVP), poly(N-vinyl pyrrolidone-co-vinyl acetate) (Copovidone), poly(ester amides) (PEA), acrylic acid (AA), polyacrylates, acrylamides, fluorinated polymers or copolymers, poly(hydroxyvalerate), poly(L-lactic acid)/polylactide (PLLA), poly(E-caprolactone), poly(lactide-co-glycolide) (PLGA), poly(hydroxybutyrate), poly(hydroxyvalerate), poly(hydroxybutyrate-co-valerate), polydioxanone, polyorthoesters, polyanhydrides, poly(glycolic acid)/polyglycolide (PGA), poly(D,L-lactic acid) (PLA), poly(glycolic acid-co-trimethylene carbonate), polyphosphoesters, polyurethanes, polyureas, polyurethane(ureas), poly(amino acids), cyanoacrylates, poly(trimethylene carbonate), poly(iminocarbonates), co-poly(etheresters), polyalkylene oxalates, polyphosphazenes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-.alpha.-olefin copolymers, vinyl halide polymers and copolymers, polyvinyl ethers, polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polyvinyl esters, copolymers of vinyl monomers with each other, olefins, poly(vinyl alcohol) (PVA), acrylonitrile butadiene (ABS) resins, ethylene-vinyl acetate copolymers, polyamides, alkyl resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, rayon, rayon-triacetate, and combinations and co-polymers thereof.

11. The endograft implant system according to claim 1 , wherein the tubular implant body is nonelastic.

12. The endograft implant system according to claim 1 , wherein the sealable circumferential collar is elastic.

13. The endograft implant system according to claim 1 , wherein the tubular body as fabricated is substantially non-linear.

14. The endograft implant system according to claim 1 , wherein the tubular body is branched.

15. The endograft implant system according to claim 1 , wherein the variable sealing device has a diameter adjusted to achieve a substantially fluid-tight seal between the sealable circumferential collar and the internal wall of the anatomic space in which it is located.

16. The endograft implant system according to claim 1 , wherein the endograft implant is a first endograft implant and is connected in series with one or more additional endograft implants to achieve a substantially fluid-tight seal between the first endograft implant and any additional endograft implant.

17. The endograft implant system according to claim 16 , wherein the first endograft implant and at least one additional endograft implant are connected in series so as to substantially exclude areas of normal lumen therebetween and to achieve a substantially fluid-tight seal between the first endograft implant and the at least one

Assignees

• Edwards Lifesciences Cardiaq Llc

Inventors

• Cartledge Richard George
• Cartledge John P

Classifications

• A61F2250/001

  for adjusting a diameter · CPC title

• A61F2/954

  for placing stents or stent-grafts in a bifurcation · CPC title

• A61F2/06

  Blood vessels · CPC title

• A61F2/90

  characterised by a net-like or mesh-like structure · CPC title

• A61B17/07207

  the staples being applied sequentially · CPC title